What does Dr. Isabelle Debergh, abdominaal chirurg do?

Dr. Isabelle Debergh, abdominaal chirurg is a specialist medical practice in Gent. Private Limited, started on 29 October 2020, 1 establishment.

What is the address of Dr. Isabelle Debergh, abdominaal chirurg?

The registered office of Dr. Isabelle Debergh, abdominaal chirurg is located at Raapstraat 4, 9031 Gent.

Is Dr. Isabelle Debergh, abdominaal chirurg still active?

Yes. According to the CBE (2 November 2026) Dr. Isabelle Debergh, abdominaal chirurg is active, legal situation “Normale toestand”, started on 29 October 2020.

Is Dr. Isabelle Debergh, abdominaal chirurg registered on Peppol?

Yes, Dr. Isabelle Debergh, abdominaal chirurg is registered on the Peppol network with ID 0208:0757603553.

What is the enterprise number of Dr. Isabelle Debergh, abdominaal chirurg?

The enterprise number of Dr. Isabelle Debergh, abdominaal chirurg is BE0757603553.

When was Dr. Isabelle Debergh, abdominaal chirurg founded?

Dr. Isabelle Debergh, abdominaal chirurg was founded on 29 October 2020.

Who are the directors of Dr. Isabelle Debergh, abdominaal chirurg?

According to the 2025 annual accounts, the directors of Dr. Isabelle Debergh, abdominaal chirurg are: Isabelle Debergh.

Is Dr. Isabelle Debergh, abdominaal chirurg a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 29 October 2020; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 1 events from the Belgian Official Gazette processed.

How much profit did Dr. Isabelle Debergh, abdominaal chirurg make in 2025?

Dr. Isabelle Debergh, abdominaal chirurg posted a profit after taxes of € 245,964 in financial year 2025.

What is the revenue of Dr. Isabelle Debergh, abdominaal chirurg?

As a small company, Dr. Isabelle Debergh, abdominaal chirurg is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 428,096.

Dr. Isabelle Debergh, abdominaal chirurg (Private Limited)

Dossier Dr. Isabelle Debergh, abdominaal chirurg, printed on 2 November 2026 from databakkes.be/en/0757603553/dr-isabelle-debergh-abdominaal-chirurg. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Isabelle Debergh, abdominaal chirurg from Gent, company number BE0757603553, closed financial year 2025 with a result of € 245,964 after tax. For that financial year Dr. Isabelle Debergh, abdominaal chirurg recorded a gross margin of € 428,096 and equity of € 649,934. Compared with financial year 2024, the result moved from € 186,185 to € 245,964. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 20, 2026.

What it is worth Growing

€ 649,934

▲ 18% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 245,964

▲ 32% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 320,538

▲ 33% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 147,883 paid out

60 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 30,960

▼ 27% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 221,997

▼ 29% vs 2024

€ 92,302 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 5,005

▲ 54% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 94,544

▲ 181% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 270,380 Gross margin 2022: € 270,380 First fiscal year in the series	€ 173,747 Gross margin 2023: € 173,747 ▼ 36% vs 2022 (€ 270,380) Unfavourable step	€ 341,289 Gross margin 2024: € 341,289 ▲ 96% vs 2023 (€ 173,747) Favourable step	€ 428,096 Gross margin 2025: € 428,096 ▲ 25% vs 2024 (€ 341,289) Favourable step	▲ 25%
Profit after taxes	€ 143,276 Profit after taxes 2022: € 143,276 First fiscal year in the series	€ 72,720 Profit after taxes 2023: € 72,720 ▼ 49% vs 2022 (€ 143,276) Unfavourable step	€ 186,185 Profit after taxes 2024: € 186,185 ▲ 156% vs 2023 (€ 72,720) Favourable step	€ 245,964 Profit after taxes 2025: € 245,964 ▲ 32% vs 2024 (€ 186,185) Favourable step	▲ 32%
Equity	€ 294,547 Equity 2022: € 294,547 First fiscal year in the series	€ 366,468 Equity 2023: € 366,468 ▲ 24% vs 2022 (€ 294,547) Favourable step	€ 551,853 Equity 2024: € 551,853 ▲ 51% vs 2023 (€ 366,468) Favourable step	€ 649,934 Equity 2025: € 649,934 ▲ 18% vs 2024 (€ 551,853) Favourable step	▲ 18%
Total debts	€ 551,450 Total debts 2022: € 551,450 First fiscal year in the series	€ 421,804 Total debts 2023: € 421,804 ▼ 24% vs 2022 (€ 551,450) Favourable step	€ 355,476 Total debts 2024: € 355,476 ▼ 16% vs 2023 (€ 421,804) Favourable step	€ 325,658 Total debts 2025: € 325,658 ▼ 8% vs 2024 (€ 355,476) Favourable step	▼ 8%
Cash	€ 271,750 Cash 2022: € 271,750 First fiscal year in the series	€ 107,198 Cash 2023: € 107,198 ▼ 61% vs 2022 (€ 271,750) Unfavourable step	€ 240,677 Cash 2024: € 240,677 ▲ 125% vs 2023 (€ 107,198) Favourable step	€ 320,538 Cash 2025: € 320,538 ▲ 33% vs 2024 (€ 240,677) Favourable step	▲ 33%
Land & buildings	€ 20,091 Land & buildings 2022: € 20,091 First fiscal year in the series	€ 20,591 Land & buildings 2023: € 20,591 ▲ 2% vs 2022 (€ 20,091) Unchanged	€ 18,289 Land & buildings 2024: € 18,289 ▼ 11% vs 2023 (€ 20,591) Unchanged	€ 15,988 Land & buildings 2025: € 15,988 ▼ 13% vs 2024 (€ 18,289) Unchanged	▼ 13%
Retained profit	€ 289,547 Retained profit 2022: € 289,547 First fiscal year in the series	€ 361,468 Retained profit 2023: € 361,468 ▲ 25% vs 2022 (€ 289,547) Favourable step	€ 546,853 Retained profit 2024: € 546,853 ▲ 51% vs 2023 (€ 361,468) Favourable step	€ 644,934 Retained profit 2025: € 644,934 ▲ 18% vs 2024 (€ 546,853) Favourable step	▲ 18%
Dividend	€ 800 Dividend 2022: € 800 First fiscal year in the series	€ 800 Dividend 2023: € 800 Unchanged (€ 800) Unchanged	€ 800 Dividend 2024: € 800 Unchanged (€ 800) Unchanged	€ 147,883 Dividend 2025: € 147,883 ▲ € 147,083 vs 2024 (€ 800) Unchanged	▲ € 147,083
Bank debt	€ 429,468 Bank debt 2022: € 429,468 First fiscal year in the series	€ 404,684 Bank debt 2023: € 404,684 ▼ 6% vs 2022 (€ 429,468) Favourable step	€ 313,661 Bank debt 2024: € 313,661 ▼ 22% vs 2023 (€ 404,684) Favourable step	€ 221,997 Bank debt 2025: € 221,997 ▼ 29% vs 2024 (€ 313,661) Favourable step	▼ 29%
Balance sheet total	€ 845,997 Balance sheet total 2022: € 845,997 First fiscal year in the series	€ 788,272 Balance sheet total 2023: € 788,272 ▼ 7% vs 2022 (€ 845,997) Unchanged	€ 907,330 Balance sheet total 2024: € 907,330 ▲ 15% vs 2023 (€ 788,272) Unchanged	€ 975,592 Balance sheet total 2025: € 975,592 ▲ 8% vs 2024 (€ 907,330) Unchanged	▲ 8%

Key figures of Dr. Isabelle Debergh, abdominaal chirurg, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Isabelle Debergh, abdominaal chirurg?

What happened at Dr. Isabelle Debergh, abdominaal chirurg in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 20, 2026 New annual accounts for financial year 2025: profit of € 245,964 (▲ 32% vs 2024). filed late Source: NBB ↗
Nov 3, 2020 Incorporation, published in the Gazette. Source: Staatsblad ↗
Oct 29, 2020 New establishment in Gent. KBO

In short

From € 143,276 profit in 2022 to € 245,964 profit in 2025.

Paid € 286,543 in corporate taxes since 2022.

Best year ever: 2025, with € 245,964 profit.

Paid out € 150,283 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Isabelle Debergh

Dr. Isabelle Debergh, abdominaal chirurg

Behind Dr. Isabelle Debergh, abdominaal chirurg is Isabelle Debergh.

Directors

According to the 2025 annual accounts

Isabelle Debergh

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Raapstraat 4

9031 Gent

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Shareholders according to the Official Gazette deeds

Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.

Incorporation

3 November 2020 Source: Deed ↗

DEBERGH Isabelle Maria Cornelia(oprichter) 100%

Details

Company number: 0757.603.553
VAT number: BE 0757.603.553
Registered office: Raapstraat 4, 9031 Gent
Names & denominations: Dr. Isabelle Debergh, abdominaal chirurg
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 29 October 2020
Peppol: Active · Active since 18 Dec 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗